Amoxapine

FDA Approved: * May 11, 1989
Pharm Company: * WATSON LABS
Category: Antidepressant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Amoxapine Overview

Amoxapine, sold under the brand name Asendin among others, is a tricyclic antidepressant (TCA). It is the N-demethylated metabolite of loxapine. Amoxapine first received marketing approval in the United States in 1992 (approximately 30 to 40 years after most of the other TCAs were introduced in the United States).[1] Contents 1 Medical uses 2 Contraindications 2.1 Lactation 3 Side effects 4 Overdose 5 Pharmacology 5.1 Pharmacodynamics 5.2 Pharmacokinetics 6 Society a...

Read more Amoxapine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amoxapine

Recent Amoxapine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Amoxapine: (5 results)

Sorted by National Drug Code

• 0591-5713 Amoxapine 25 mg Oral Tablet by Watson Laboratories, Inc.
• 0591-5714 Amoxapine 50 mg Oral Tablet by Watson Laboratories, Inc.
• 0591-5715 Amoxapine 100 mg Oral Tablet by Watson Laboratories, Inc.
• 0591-5716 Amoxapine 150 mg Oral Tablet by Watson Laboratories, Inc.
• 54868-2438 Amoxapine 50 mg Oral Tablet by Physicians Total Care, Inc.

Other drugs which contain Amoxapine or a similar ingredient: (1 result)

• ASENDIN Amoxapine2 discussions